Driving Positive Progress for Sites

The Site Advisory Council (SAC) is a collaborative group of leaders from clinical research sites dedicated to enabling more efficient clinical trials. The Council brings actionable solutions to systemic industry challenges, focusing on initiatives that will drive positive progress for the majority of research sites.
Members represent diverse institutions including NYU, UCLA, Penn, MSK, Vanderbilt, and other leading clinical research organizations across the country.
Veeva facilitates the SAC by providing platform resources, public policy support, and connections to the One Clinical Council to secure industrywide buy-in for solutions.
KT-0760

About the Council

The Site Advisory Council brings together a diversity of clinical research leaders
organized into 3 distinct Working Groups
Picture1

15

Council Members

Picture1-2

3

Working Groups

Picture1-1

14

Research Institutions

Addressing the burden of redundant or irrelevant training requirements.

The working group is focused on how Site Initiation Visit Training translate into early operational friction, with the goal of  identifying pathways that directly improve clinical trial readiness, execution, and early operational performance.

Initiatives:

The Site Initiation Visit (SIV) Training Effectiveness Survey is the first of its kind, intended to collect industry-wide data on site initiation visit quality and effectiveness. It correlates "Readiness Gaps" and initial patient enrollment to identify how early training impacts downstream clinical performance in interventional clinical trials.

Responses gathered will be used for quality analysis and anonymized before being leveraged for insights. 

Focusing on financial management challenges, with emphasis on the prevalent issues around clinical research sites not being paid on time or in accordance with their clinical trial agreements.

Initiatives:

The members have developed a sponsor payments survey to capture real world data on complications with payment timeliness. This will enable  insights which can be leveraged to improve this process across sites and sponsors.

 

Optimizing feasibility processes, with focus on reducing redundancy and improving efficiency.

Initiatives: 

The group is currently developing a standardized set of feasibility questions, which when leveraged across sponsors, can reduce survey turnaround times and site burden.

A site-driven pilot of these standardized questions is underway. Participating sites will fill out the standard questions and proactively share them with sponsors prior to completing brand new feasibility requests. 

Meet the Site Advisory Council Members

 Uniting distinguished clinical research site leaders

Training Working Group

Streamlining training requirements

Meghan Blair

Director, Regulatory Affairs

Penn Medicine

Tina Bowdish

Director Research Network Development

Advent Health

Feasibility Working Group

Addressing feasibility inefficiency 

Christina Brennan

Senior Vice President, Clinical Research

Northwell Health

Danielle Rao

Clinical Research Program Manager

Cayuga Medical

Keith Snyder-Dyer

Executive Director of Clinical Research

The Crofoot Research Center, Inc.

Kristin Herman

Executive Director of Clinical Trials

Thomas Jefferson University

Theresa Oswald

Director, Research Operations and Conduct

Ann & Robert H. Lurie Children's Hospital of Chicago

Sponsor Payments Working Group

Improving sponsor payment efficiency

Adnan Rangwala

Senior Director, Research IT

NYU Langone Health

Alisha Garibaldi

Vice President, Clinical Research

Skylight Health Research

Bishoy Anastasi

Sr. Director, Clinical Research Finance & Strategy

UCLA

Join the Conversation

The Site Advisory Council will present its findings and lead collaborative discussion at Veeva Summit

October 19-21 in Boston

Summit is free to attend!